These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8588234

  • 1. Using cyclosporine Neoral immediately after liver transplantation. United Kingdom Neoral Pilot Study Group.
    Tredger JM.
    Ther Drug Monit; 1995 Dec; 17(6):638-41. PubMed ID: 8588234
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG, Mayer AD, Clavien PA, Cavallari A, Gunawardena KA, Mueller EA.
    Transplantation; 1998 Dec 27; 66(12):1632-40. PubMed ID: 9884251
    [Abstract] [Full Text] [Related]

  • 3. An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral.
    Pasha TM, Wiesner RH, Dahlke LM, Porayko MK, Krom RA.
    Liver Transpl Surg; 1998 Sep 27; 4(5):410-5. PubMed ID: 9724479
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec 27; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 5. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group.
    Transplantation; 2001 Sep 27; 72(6):1024-32. PubMed ID: 11579295
    [Abstract] [Full Text] [Related]

  • 6. NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation.
    Alvarez F, Atkison PR, Grant DR, Guilbault N, Jones AB, Kim PS, Kneteman NM, Laurin L, Martin SR, Murphy GF, Paradis K, Shapiro J, Smith LJ, Superina RA.
    Transplantation; 2000 Jan 15; 69(1):87-92. PubMed ID: 10653385
    [Abstract] [Full Text] [Related]

  • 7. Experience with neoral versus sandimmune in primary liver transplant recipients.
    Pinson CW, Chapman WC, Wright JK, Hunter EB, Awad JA, Raiford DS, Payne JL, Geevarghese S, Blair TK, Van Buren DH.
    Transpl Int; 1998 Jan 15; 11 Suppl 1():S278-83. PubMed ID: 9664997
    [Abstract] [Full Text] [Related]

  • 8. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.
    Ann Chir; 1998 Jan 15; 52(8):716-21. PubMed ID: 9846420
    [Abstract] [Full Text] [Related]

  • 9. Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation.
    Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Dahlke LJ, Wilson SM, Steers JL, Krom RA.
    Transplantation; 1997 Sep 15; 64(5):726-31. PubMed ID: 9311710
    [Abstract] [Full Text] [Related]

  • 10. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.
    Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RW.
    Transplantation; 1999 Nov 15; 68(9):1325-31. PubMed ID: 10573071
    [Abstract] [Full Text] [Related]

  • 11. Neoral in de novo liver transplantation: adequate immunosuppression without intravenous cyclosporine.
    Levy GA, Rasmussen A, Mayer AD, Jamieson NV, Neuhaus P.
    Liver Transpl Surg; 1997 Nov 15; 3(6):571-7. PubMed ID: 9404955
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P, Niese D.
    Kidney Int; 1998 Sep 15; 54(3):938-44. PubMed ID: 9734620
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID, Thomson M, Kelly DA.
    Liver Transpl Surg; 1999 Mar 15; 5(2):107-11. PubMed ID: 10071349
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
    Trull A, Steel L, Sharples L, Stewart S, Parameshwar J, McNeil K, Wallwork J.
    Ther Drug Monit; 1999 Feb 15; 21(1):17-26. PubMed ID: 10051050
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K, Davidson BR, Burroughs AK.
    Transplantation; 1999 Oct 27; 68(8):1195-8. PubMed ID: 10551650
    [Abstract] [Full Text] [Related]

  • 18. Induction of immunosuppression by microemulsion cyclosporine in liver transplantation.
    Rasmussen A, Hjortrup A, Hansen B, Heslet L, Kirkegaard P.
    Transplantation; 1996 Oct 15; 62(7):1031-3. PubMed ID: 8878402
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
    Fukudo M, Yano I, Masuda S, Katsura T, Ogura Y, Oike F, Takada Y, Tanaka K, Inui K.
    Liver Transpl; 2006 Feb 15; 12(2):292-300. PubMed ID: 16447186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.